Indeed, when restricting analysis to families exclusively consisting of JAK2-positive members, we observed a significant trend toward JAK2 GGCC enrichment in familial MPN compared to sporadic MPN (P= 0.046; Supporting Information Table 4). The gene discussed is JAK2; the disease is myeloproliferative neoplasm.